Research programme: echo gas liposomal - Mebiopharm

Drug Profile

Research programme: echo gas liposomal - Mebiopharm

Alternative Names: Echo gas nano bubble - Mebiopharm; Echo gas ultrasound contrast agent - Mebiopharm; Nanoparticle contrast agent - Mebiopharm

Latest Information Update: 03 Nov 2016

Price : $50

At a glance

  • Originator Mebiopharm; Unknown
  • Developer Mebiopharm
  • Class Contrast media; Diagnostic agents
  • Mechanism of Action Ultrasonography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 03 Nov 2016 No development reported for Cancer (Diagnosis) in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top